N6-Methyladenosine Regulator-Mediated RNA Methylation Is Involved in Primary Sjögren's Syndrome Immunoinfiltration

The crucial role of epigenetic regulation, especially the modifications of RNA N6-methyladenosine (m6A), in immunity is a current research hotspot. However, the m6A modifications in primary Sjögren's syndrome (pSS) and the immune infiltration pattern they govern remain unknown. Thus, the patterns of 23 m6A regulator-mediated RNA modifications in parotid or blood samples from pSS patients were evaluated by bioinformatics analysis in the current study. Comparing m6A regulators between control and pSS patients showed that m6A regulators are associated with pSS, and regulators also had differential correlations. Further clustering analysis and comparison of gene expression and immune cell infiltration between m6A modification patterns revealed that each modification pattern had its own unique genetic and immune profile. Multiple immune cell infiltrations were differentially expressed between the patterns. The enrichment of gene ontology between the two patterns in parotid was concentrated on RNA metabolism and processing. The KEGG pathway enrichment and weighted correlation network analysis further showed that the autophagy pathway might be involved in the m6A modification patterns in pSS. Together, these findings suggest that m6A regulators play a certain role in the immune cell infiltration of parotid tissue in pSS.

[1]  Liting Jiang,et al.  A Link Between Mitochondrial Dysfunction and the Immune Microenvironment of Salivary Glands in Primary Sjogren’s Syndrome , 2022, Frontiers in Immunology.

[2]  J. Kusukawa,et al.  Mast cells can produce transforming growth factor β1 and promote tissue fibrosis during the development of Sjögren’s syndrome-related sialadenitis , 2021, Modern Rheumatology.

[3]  Minqi Li,et al.  m6A regulator‐mediated RNA methylation modification patterns are involved in immune microenvironment regulation of periodontitis , 2021, Journal of cellular and molecular medicine.

[4]  F. He,et al.  METTL3 restrains papillary thyroid cancer progression via m6A/c-Rel/IL-8 mediated neutrophils infiltration. , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  Nadezhda T. Doncheva,et al.  The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets , 2020, Nucleic Acids Res..

[6]  M. Gershwin,et al.  Immunobiology of T Cells in Sjögren’s Syndrome , 2020, Clinical Reviews in Allergy & Immunology.

[7]  Jianjun Chen,et al.  m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer. , 2020, Cancer cell.

[8]  Hailing Shi,et al.  m6A mRNA methylation controls autophagy and adipogenesis by targeting Atg5 and Atg7 , 2020, Autophagy.

[9]  J. Priyadharsini,et al.  Implications of m6A modification in autoimmune disorders , 2019, Cellular & Molecular Immunology.

[10]  Olga Tanaseichuk,et al.  Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.

[11]  Hongjun Song,et al.  Fragile X mental retardation protein modulates the stability of its m6A‐marked messenger RNA targets , 2018, Human molecular genetics.

[12]  Yu-Sheng Chen,et al.  Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism , 2018, Cell Research.

[13]  Tao Pan,et al.  Dynamic RNA Modifications in Gene Expression Regulation , 2017, Cell.

[14]  R. Morita,et al.  Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjögren’s syndrome , 2017, Annals of the rheumatic diseases.

[15]  J. Kelder,et al.  Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjögren’s syndrome , 2017, Rheumatology International.

[16]  Yuri Motorin,et al.  Detecting RNA modifications in the epitranscriptome: predict and validate , 2017, Nature Reviews Genetics.

[17]  Chengqi Yi,et al.  Epitranscriptome sequencing technologies: decoding RNA modifications , 2016, Nature Methods.

[18]  Wei Yan,et al.  Epigenetic inheritance of acquired traits through sperm RNAs and sperm RNA modifications , 2016, Nature Reviews Genetics.

[19]  Samie R. Jaffrey,et al.  m6A RNA methylation promotes XIST-mediated transcriptional repression , 2016, Nature.

[20]  T. Aune,et al.  Long non-coding RNAs in innate and adaptive immunity. , 2016, Virus research.

[21]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[22]  V. Narry Kim,et al.  Emerging Roles of RNA Modification: m6A and U-Tail , 2014, Cell.

[23]  Samir Adhikari,et al.  Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase , 2014, Cell Research.

[24]  Steve Horvath,et al.  Systems analysis of primary Sjögren's syndrome pathogenesis in salivary glands identifies shared pathways in human and a mouse model , 2012, Arthritis Research & Therapy.

[25]  J. Pers,et al.  B cells in Sjögren's syndrome: from pathophysiology to diagnosis and treatment. , 2012, Journal of autoimmunity.

[26]  E. Terzioğlu,et al.  The numbers of Foxp3 + Treg cells are positively correlated with higher grade of infiltration at the salivary glands in primary Sjögren's syndrome , 2010, Lupus.

[27]  S. Pillemer,et al.  Immunopathology and Infectious Diseases Systemic and Local Interleukin-17 and Linked Cytokines Associated with Sjögren ’ s Syndrome Immunopathogenesis , 2010 .

[28]  Ben S. Wittner,et al.  Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 , 2009, Nature.

[29]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[30]  Ke Chen,et al.  T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome. , 2007, The Journal of rheumatology.

[31]  Julie C Kiefer,et al.  Epigenetics in development , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[32]  A. Vissink,et al.  Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's syndrome. , 2007, Rheumatology.

[33]  S. Horvath,et al.  Statistical Applications in Genetics and Molecular Biology , 2011 .

[34]  X. Mariette,et al.  Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome , 2004, The Journal of pathology.

[35]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[36]  Gary D. Bader,et al.  An automated method for finding molecular complexes in large protein interaction networks , 2003, BMC Bioinformatics.

[37]  R. Jonsson,et al.  Subcellular distribution of aquaporin 5 in salivary glands in primary Sjögren's syndrome , 2001, The Lancet.

[38]  L. Li,et al.  Association of mast cells with fibrosis and fatty infiltration in the minor salivary glands of patients with Sjögren's syndrome. , 1998, Clinical and experimental rheumatology.

[39]  R. Nussbaum,et al.  Essential role for KH domains in RNA binding: Impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome , 1994, Cell.

[40]  R. Bone,et al.  Primary Sjogren syndrome: clinical and immunopathologic features. , 1984, Seminars in arthritis and rheumatism.